CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
Rheumatology (Oxford)
.
2019 Mar 1;58(3):557.
doi: 10.1093/rheumatology/key425.
Authors
Kaiwen Wang
1
,
Jiangfeng Zhao
1
,
Zhiwei Chen
1
,
Ting Li
1
,
Xiaoming Tan
2
,
Yu Zheng
2
,
Liyang Gu
1
,
Li Guo
1
,
Fangfang Sun
1
,
Haiting Wang
1
,
Jiajie Li
1
,
Xiaodong Wang
1
,
Gabriela Riemekasten
3
,
Shuang Ye
1
Affiliations
1
Department of Rheumatology, Ren Ji Hospital South Campus, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.
2
Department of Pulmonology, Ren Ji Hospital South Campus, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.
3
Department of Rheumatology and Clinical Immunology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
PMID:
30590756
DOI:
10.1093/rheumatology/key425
No abstract available
Publication types
Published Erratum